Scalper1 News
Big pharma Bristol-Myers Squibb’s (BMY) stock was selling off nearly 3% in heavy morning trading in the stock market today. There was no news from the company, but one possible reason was that it posted a new clinical trial of nivolumab in non-small-cell lung cancer (NSCLC). The new trial studies only patients with the PD-L1 biomarker, and does not combine nivolumab with any other agents. The company is already conducting another study of the Scalper1 News
Scalper1 News